258 related articles for article (PubMed ID: 23026133)
1. The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism.
Chinnaiyan P; Kensicki E; Bloom G; Prabhu A; Sarcar B; Kahali S; Eschrich S; Qu X; Forsyth P; Gillies R
Cancer Res; 2012 Nov; 72(22):5878-88. PubMed ID: 23026133
[TBL] [Abstract][Full Text] [Related]
2. Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
Prabhu AH; Kant S; Kesarwani P; Ahmed K; Forsyth P; Nakano I; Chinnaiyan P
Neuro Oncol; 2019 Feb; 21(3):337-347. PubMed ID: 30476237
[TBL] [Abstract][Full Text] [Related]
3. Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth.
Prabhu A; Sarcar B; Kahali S; Yuan Z; Johnson JJ; Adam KP; Kensicki E; Chinnaiyan P
Cancer Res; 2014 Feb; 74(3):787-96. PubMed ID: 24351290
[TBL] [Abstract][Full Text] [Related]
4. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.
Zhao H; Heimberger AB; Lu Z; Wu X; Hodges TR; Song R; Shen J
Oncotarget; 2016 Apr; 7(15):20486-95. PubMed ID: 26967252
[TBL] [Abstract][Full Text] [Related]
6. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis of the mesenchymal signature landscape in gliomas.
Celiku O; Tandle A; Chung JY; Hewitt SM; Camphausen K; Shankavaram U
BMC Med Genomics; 2017 Mar; 10(1):13. PubMed ID: 28279210
[TBL] [Abstract][Full Text] [Related]
8. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
[TBL] [Abstract][Full Text] [Related]
9. Molecular and genetic profiling in human gliomas.
Palanichamy K; Erkkinen M; Saia G; Chakravarti A
Discov Med; 2007 Jun; 7(38):75-81. PubMed ID: 18093469
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic signature of brain cancer.
Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
[TBL] [Abstract][Full Text] [Related]
12. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
13. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
Patil V; Mahalingam K
Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of human gliomas assessed with NMR.
Lee JE; Jeun SS; Kim SH; Yoo CY; Baek HM; Yang SH
J Clin Neurosci; 2019 Oct; 68():275-280. PubMed ID: 31409545
[TBL] [Abstract][Full Text] [Related]
16.
D'Alessandro G; Quaglio D; Monaco L; Lauro C; Ghirga F; Ingallina C; De Martino M; Fucile S; Porzia A; Di Castro MA; Bellato F; Mastrotto F; Mori M; Infante P; Turano P; Salmaso S; Caliceti P; Di Marcotullio L; Botta B; Ghini V; Limatola C
Cell Commun Signal; 2019 Aug; 17(1):108. PubMed ID: 31455353
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
[TBL] [Abstract][Full Text] [Related]
18. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
19. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme.
Heiland DH; Gaebelein A; Börries M; Wörner J; Pompe N; Franco P; Heynckes S; Bartholomae M; hAilín DÓ; Carro MS; Prinz M; Weber S; Mader I; Delev D; Schnell O
Mol Cancer Res; 2018 Apr; 16(4):655-668. PubMed ID: 29330292
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
